In re Roundup Products Liability Litigation, 3:16-md-02741

This case concerns the distribution of a "common benefit fund" established in the Roundup MDL (multidistrict litigation), which consolidated federal cases alleging Monsanto’s Roundup weed killer causes non-Hodgkin lymphoma.
The fund was created from an 8% holdback of attorneys’ fees paid by all lawyers who secured recoveries in the MDL.
Seven law firms applied for disbursements, most of which held leadership roles in the MDL; their work included major bellwether trials and settlement negotiations.
The Special Master, appointed to advise on distribution, found significant factual and procedural overlap between MDL and state court cases, making the benefits attributable to MDL leadership work difficult to quantify or allocate equitably.
Major victories in bellwether trials increased both the caseload and settlement pressure on Monsanto but benefited both MDL and non-MDL plaintiffs.
The Special Master recommends refunding the deposits to each firm rather than attempting a redistribution, given the practical, jurisdictional, and fairness concerns.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Should common benefit funds be redistributed?	Lead counsel: Our work created global benefits, justifying redistribution from the fund.	Non-lead counsel: The benefits are diffuse, often public, and MDL work is not the sole or dominant factor in outcomes.	No redistribution; refund deposits to firms.
Was there enough identifiable "common benefit" work to justify taking fees from non-lead firms?	Our MDL work (e.g., document prep, bellwethers) directly reduced costs & risk for others.	Public filings and state court overlap undermine traceability and exclusivity of benefits.	No sufficient basis for fee transfer.
Is it fair/equitable to tax only MDL participants but not others who benefited from MDL work?	Fair because MDL firms directly benefited from lead counsel work.	Unfair and arbitrary since benefits also flowed to state court firms not subject to 8% holdback.	Imposing tax only on MDL firms is unfair.
Can/should the court divide the common benefit fund among MDL lead counsel only?	Yes; leadership work warrants premium.	Fee-splitting among lead counsel is arbitrary & not reliably precise.	Infeasible to allocate fairly—even among lead counsel.

Boeing Co. v. Van Gemert, 444 U.S. 472 (1980) (articulates standards for awarding common benefit funds in class/aggregate litigation)
Hall v. Cole, 412 U.S. 1 (1973) (discusses justification and jurisdiction for equitable fee shifting)
Mills v. Electric Auto-Lite, 396 U.S. 375 (1970) (addresses circumstances where fee-shifting is permissible in collective litigation)
Vincent v. Hughes Air West, Inc., 557 F.2d 759 (9th Cir. 1977) (original claimant cannot shift fees to third parties who appear and hire own attorneys)